Open AccessSafety and Efficacy of Belimumab in Patients with Lupus Nephritis
Author(s) -
Richard Furie,
Brad H. Rovin,
Frédéric Houssiau,
Gabriel Contreras,
Y.K. Onno Teng,
Paula Curtis,
Yulia Green,
Mohamed Okily,
Anuradha Madan,
David A. Roth
Publication year - 2022
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02520322
Subject(s) - belimumab , medicine , placebo , adverse effect , lupus nephritis , post hoc analysis , population , b cell activating factor , immunology , pathology , antibody , disease , alternative medicine , b cell , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom